Takeda Pharmaceutical Limited (TAK) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Takeda Pharmaceutical Company Limited  (NYSE: TAK)


Takeda Pharmaceutical Limited's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Takeda Pharmaceutical Limited's ROA in the fourth quarter of 2025?
Takeda Pharmaceutical Company Limited achieved a return on average assets (ROA) of 0.73 % in its fourth quarter of 2025, which is below Takeda Pharmaceutical Limited's average return on assets, which stands at 1.5%.

ROA fell compared to the third quarter of 2025, despite the net income growth of % from the third quarter of 2025.

However, within the Healthcare sector 190 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 2301.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2024)
IV. Quarter
Y / Y Total Assets Change -12.18 % 6.88 % -12.18 % -12.18 % 6.88 %
Y / Y Net Income Change -30.16 % - - - -55.09 %
Net Income (TTM) in million 689 986 986 986 986
Return On Assets (TTM) 0.73 % 1.02 % 1.03 % 1 % 0.97 %
TAK's Total Ranking # 2301 # # # # 2275
Total Assets (TTM) in million 90,760 103,353 90,760 90,760 103,353
Seq. Total Assets Change -12.18 % 13.88 % 0 % -12.18 % 6.88 %
Seq. Net Income Change - - - - -

TAK's 5 Years Annual ROA >> Back to TAK Management Effectiveness >> Compare TAK ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 61
Sector # 191
Overall # 2271

Return On Assets Statistics
High Average Low
2.91 %
1.5 %
0.34 %
(Mar 31 2021)   (Mar 31 2020)





Financial Statements
Takeda Pharmaceutical Limited's Assets $ 90,760 million TAK's Balance sheet
Takeda Pharmaceutical Limited's Income $ 689 million Quarterly TAK's Income Statement
TAK's Income by Division See TAK's Income by Division



Annual Return On Assets (Mar 31 2025)
FY 2025		 (Mar 31 2024)
FY 2024		 (Mar 31 2023)
FY 2023		 (Mar 31 2022)
FY 2022		 (Mar 31 2021)
FY 2021
Y / Y Total Assets Change -12.18 % 6.88 % 0.23 % -16.99 % 2.36 %
Total Assets in million 90,760 103,353 96,699 96,480 116,229
Y / Y Net Income Change -30.16 % -55.09 % 30.34 % -50.23 % 731.02 %
Net Income in million 689 986 2,196 1,685 3,386
Annual Return On Assets 0.76 % 0.95 % 2.27 % 1.75 % 2.91 %

TAK's 5 Years Annual ROA >> Back to TAK Management Effectiveness >> Compare TAK ROA to its Competitors



Comment on TAK's ROA in the fiscal year ending 2025
In the fiscal year 2025 Takeda Pharmaceutical Limited's ROA decreased compared to previous year to 0.76 %, due to deterioration of net income -30.16 % to $688.86 million, from $986.39 million a year ago, as TAK's assets were $90,760.14 million.


More Return On Assets Ratios
TAK's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TAK's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TAK's Competitors
Subscribers only: Roa for Takeda Pharmaceutical Limited's Suppliers
Subscribers only: Return On Assets for TAK's Customers

You may also want to know
TAK's Roi TAK's Inventory Turnover Ratio TAK's Growth Rates TAK's Dividend Comparisons
TAK's Profitability Ratios TAK's Asset Turnover Ratio TAK's Dividend Growth
TAK's Roe TAK's Valuation Ratios TAK's Financial Strength Ratios TAK's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector ROA
Adapthealth Corp   2.01 %
Privia Health Group Inc   1.76 %
Monte Rosa Therapeutics Inc   1.65 %
Aytu Biopharma Inc  1.38 %
Vaso Corporation  1.37 %
Veru Inc   1.34 %
Bruker Corporation  1.32 %
Pacs Group Inc   1.12 %
Brightspring Health Services Inc   0.95 %
Amneal Pharmaceuticals Inc   0.94 %
Black Hawk Acquisition Corporation  0.92 %
American Shared Hospital Services  0.90 %
Sotera Health Company  0.80 %
Takeda Pharmaceutical Company Limited  0.76 %
Vericel Corporation  0.73 %
Keros Therapeutics Inc   0.69 %
Incyte Corporation  0.41 %
Aveanna Healthcare Holdings Inc   0.33 %
Cryo cell International Inc   0.20 %

Date modified: 2026-07-07T13:58:33+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.